| Literature DB >> 35432765 |
Li Lin1, Si-Bo Yuan2, Huan Guo1.
Abstract
BACKGROUND: Complete mesocolic excision (CME) with central vascular ligation (CVL) was proposed by Hohenberger in 2009. The CME principle has gradually become the technical standard for colon cancer surgery. How to achieve CME with CVL in laparoscopic right hemicolectomy (LRH) is controversial, and a unified standard approach is not yet available. In recent years, the authors' team has integrated the theory of membrane anatomy, tried to combine the cephalic approach with the classic medial approach (MA) for technical optimization, and proposed a cranial-medial mixed dominant approach (CMA). AIM: To explore the feasibility of operational approaches for LRH with CME.Entities:
Keywords: Colon cancer; Complete mesocolic excision; Embryology; Laparoscopic surgery; Mesocolon; Right hemicolectomy
Year: 2022 PMID: 35432765 PMCID: PMC8984517 DOI: 10.4240/wjgs.v14.i3.221
Source DB: PubMed Journal: World J Gastrointest Surg
Figure 1Flow chart of clinical data selection.
Basic patient preoperative characteristics
|
|
|
|
|
| Age (yr) | 63.12 ± 13.65 | 61.35 ± 12.27 | 0.61 |
| Sex | 0.794 | ||
| Male | 14 | 18 | |
| Female | 12 | 13 | |
| BMI (kg/m2) | 21.42 ± 3.15 | 22.54 ± 3.43 | 0.209 |
| Tumour size (cm) | 5.18 ± 1.80 | 4.84 ± 2.06 | 0.52 |
| Previous abdominal surgery | 0.488 | ||
| Yes | 3 | 6 | |
| No | 23 | 25 | |
| Tumour location | 0.644 | ||
| Ileocecal junction | 7 | 6 | |
| Ascending colon | 11 | 12 | |
| Flexura hepatica coli | 8 | 13 | |
| Histological grade | 0.185 | ||
| Well | 0 | 1 | |
| Moderate | 18 | 26 | |
| Poor | 8 | 4 |
CMA: Cranial-medial mixed dominant approach; MA: Medial approach.
Figure 2The position of the five trocars.
Figure 3The cranial-medial mixed dominant approach. A: The right fusion fascia area of the transverse mesocolon and the mesogastrium. The black arrow indicates the position of the first cut with dissection along the dotted line; B: Expanded surgical plane between the fusion fascia of Fredet and the visceral duodenal-pancreatic peritoneum; C: High-risk area using the superior right colic vein as a landmark included the gastrocolic trunk of Henle, middle colic vein (MCV), and middle colic artery (MCA); D: The mesentery junction fusion point of the mesocolon and the intestinal mesentery, approximately 3 cm below the projection of ileocolic vessels to the confluence of the superior mesenteric vein (SMV); E: The mesocolic window was opened to enter the right retrocolic space; F: Expanded surgical plane of the right retrocolic space between the ventral side of the fusion fascia of Toldt and deep subperitoneal fascia. A line: Red dotted line, B line: Blue dotted line, as indicated by Shinohara[15]; G: Fusion fascia of Fredet; H: Right retrocolic space after resection between the fusion fascia of Toldt and deep subperitoneal fascia; I: Rendezvous view of the surgical plane after the cephalic-approach procedure and medial-approach procedure, cut along the black dotted line on the fusion fascia of Fredet; J: Complex three-dimensional anatomical structure of the root of medial colic vessels; K: Three-dimensional dissection of the mesocolon around the root of the MCVs; L: Lateral white line of Toldt around the ileocaecum; M: Cleavage of the lateral white line of Toldt around the caecum connected to the posterior plane of the expanded fusion fascia of Toldt; N: SMV after lymph node dissection. RGEV: Right gastroepiploic vein; ASPV: Anterosuperior pancreatic-duodenal vein; SRCV: Superior right colic vein; ICA: Ileocolic artery; ICV: Ileocolic vein; SMA: Superior mesenteric artery.
Figure 4The specimen from the operation.
Comparison of intraoperative and postoperative conditions between the two groups
|
|
|
|
|
| Sample length (cm) | 26.95 ± 6.18 | 27.926 ± 7.52 | 0.598 |
| No. of lymph nodes collected | 30.50 ± 15.31 | 23.81 ± 9.06 | 0.046 |
| No. of positive lymph nodes | 2.15 ± 2.99 | 1.45 ± 2.32 | 0.323 |
| Nerve invasion | 0.524 | ||
| Yes | 20 | 26 | |
| No | 6 | 5 | |
| Vessel carcinoma embolus | 0.432 | ||
| Yes | 14 | 20 | |
| No | 12 | 11 | |
| Invasive depth | 0.021 | ||
| T1 | 2 | 1 | |
| T2 | 0 | 1 | |
| T3 | 8 | 1 | |
| T4 | 16 | 28 | |
| Lymph node metastasis | 0.658 | ||
| N0 | 13 | 19 | |
| N1 | 9 | 9 | |
| N2 | 4 | 3 | |
| pTNM | |||
| 0 | 0 | 1 | 0.339 |
| I | 1 | 0 | |
| II | 12 | 16 | |
| III | 11 | 14 | |
| IV | 2 | 0 | |
| Total operation time (min) | 135.12 ± 17.47 | 150.61 ± 26.01 | 0.01 |
| Laparoscopic procedure time (min) | 69.73 ± 15.13 | 84.81 ± 21.48 | 0.003 |
| Intraoperative blood loss (mL) | 48.46 ± 30.07 | 67.10 ± 87.88 | 0.309 |
| Exhaust time (d) | 3.81 ± 1.92 | 4.45 ± 1.15 | 0.123 |
| Liquid intake time (d) | 5.27 ± 1.87 | 4.81 ± 1.22 | 0.266 |
| Postoperative hospitalization (d) | 12.23 ± 2.23 | 11.29 ± 2.02 | 0.101 |
CMA: Cranial-medial mixed dominant approach; MA: Medial approach.
Comparison of complication rates between the two groups, n (%)
|
|
|
|
|
| Complications | 6(23) | 4(13) | 0.486 |
| Anastomotic fistula | 0 | 0 | |
| Anastomotic stenosis | 0 | 0 | |
| Bleeding | 0 | 1 | |
| Lymphatic fistula | 3 | 1 | |
| Ileus | 2 | 0 | |
| Incisional hernia | 0 | 1 | |
| Acute urine retention | 0 | 0 | |
| Incision infection prevention | 1 | 1 | |
| Intra-abdominal infection | 0 | 0 | |
| Pulmonary infection | 0 | 0 |
CMA: Cranial-medial mixed dominant approach; MA: Medial approach.